Pharmaceutical Spray Drying Market, By Product Type, By Drying Configuration, By Application, By End User, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
Description
REPORT HIGHLIGHT
Pharmaceutical Spray Drying Market size was valued at US$ 2,130.30 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.
The pharmaceutical spray drying market focuses on the use of spray drying to turn liquid drug feeds such as solutions, suspensions, or emulsions into dry, free‑flowing powders with controlled particle size, shape, density, and moisture or residual solvent levels. In pharmaceutical research and manufacturing, spray drying is widely treated as more than a simple drying step because it can be used to engineer particles for specific performance targets. It is often chosen when conventional processing cannot achieve the required powder properties, especially for compounds with poor water solubility, unstable actives, or formulations that need precise control over dissolution and dispersibility.
Growth in this market is closely linked to the increasing number of poorly soluble small‑molecule candidates and the need for enabling formulation approaches such as amorphous solid dispersions, as well as the steady expansion of inhalation and nasal drug products where aerodynamic particle size is a critical quality attribute. Spray drying is also applied for taste masking, controlled release, stabilization of sensitive actives, and improving downstream manufacturability for blending, encapsulation, and tableting. For R&D and process development teams, the technology is valued for rapid formulation screening, predictable parameter-based tuning of particle properties, and a clearer path for scale-up when supported by process understanding and Quality by Design frameworks.
Pharmaceutical Spray Drying Market- Market Dynamics
More Poorly Soluble New Drugs and a Busy Approval Cycle Are Driving Spray Drying for Enabling Formulations
A key driver for the pharmaceutical spray drying market is the steady flow of new drug approvals and the growing need to “fix” molecules that do not dissolve well in water, since poor solubility often leads to low and variable absorption and forces formulation teams to use enabling approaches like spray‑dried amorphous solid dispersions or carefully engineered dry powders. The scale of development work is clear in recent approval volumes: According to the U.S. Food and Drug Administration (FDA) CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 NMEs across 2021–2024, which keeps pressure on R&D and manufacturing groups to select scalable processes early. At the pipeline level, the clinical workload remains large and continuous: According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry contains hundreds of thousands of studies overall, with tens of thousands in active or recruiting status in recent years, pointing to a wide base of programs that eventually require formulation optimization and tech transfer. On the production side, demand for reliable, repeatable manufacturing supports investment in particle engineering and drying technologies: According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing), industry shipment values in the early 2020s are reported at hundreds of billions of dollars, meaning small gains in yield, batch consistency, and cycle time can translate into meaningful cost and supply improvements. This combination of a busy approval cycle, a large clinical pipeline, and high-value manufacturing output increases the number of cases where standard crystallization or milling is not enough, making spray drying a practical choice to control particle properties, improve dissolution, and reduce scale-up risk under GMP expectations.
Pharmaceutical Spray Drying Market- Segmentation Analysis:
Outsourced spray drying and processing keeps gaining attention because the development pipeline stays busy and many drug programs need specialized GMP facilities, solvent handling, and fast tech transfer without waiting for new internal capacity. According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the database has grown to well over 400,000 registered studies in the 2020s, with tens of thousands listed as active or recruiting in recent years, which points to a steady stream of formulation and process work moving through R&D. That workload connects directly to commercial readiness, since each successful program eventually needs a scalable and documented manufacturing route. According to U.S. FDA CDER, new molecular entity approvals reached 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, which adds up to 192 NMEs over 2021–2024; this level of approvals keeps pressure on manufacturers and contract partners to lock processes, run validation campaigns, and support launches where spray drying is often considered for particle engineering and consistent powder quality.
Finished dosage manufacturing also supports demand for spray drying because commercial production places high value on batch consistency, predictable powder flow, and controlled particle properties for downstream steps like blending, filling, encapsulation, tableting, or inhalation device performance. According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing, NAICS 3254), U.S. shipment values for this industry are reported in the hundreds of billions of dollars in the early 2020s, showing how even small process gains in yield, cycle time, and deviations can matter financially at scale. Alongside this, according to U.S. FDA CDER annual drug approval reporting, the continuing flow of novel approvals through 2020–2024 supports ongoing lifecycle manufacturing activities such as scale-up, post-approval process changes, and second-source planning, all of which favor robust, repeatable powder-processing methods like spray drying when product performance depends on tight particle control.
Pharmaceutical Spray Drying Market- Geographical Insights
Pharmaceutical spray drying demand tends to concentrate in regions where drug development activity and GMP manufacturing output stay high, because spray drying is usually adopted when a pipeline exists that can move into scale-up and commercial supply. According to U.S. FDA CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 approvals across 2021–2024, which signals a steady flow of products that need manufacturing-ready formulation decisions and controlled powder processing. According to the European Medicines Agency (EMA), the agency continued to publish strong levels of evaluation and authorization activity through the early 2020s, supporting ongoing demand for advanced processing technologies in Europe where compliance and documentation expectations are high. Across Asia, investment tends to follow growth in regulated manufacturing and export-oriented production; according to the World Health Organization (WHO) regulatory system strengthening publications in the early 2020s, more countries have been progressing toward higher maturity regulatory functions, which typically supports broader adoption of GMP-aligned technologies and specialized contract manufacturing capacity.
United States Pharmaceutical Spray Drying Market- Country Insights
The United States looks like the strongest single-country opportunity because it combines approvals, clinical activity, and large-scale manufacturing economics. According to U.S. FDA CDER, the 2021–2024 NME approval run-rate remained high, with annual counts of 50, 37, 55, and 50, which keeps launch timelines and lifecycle manufacturing work active and encourages investment in scalable particle engineering routes such as spray drying. Development depth also remains visible; according to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry includes well over 400,000 studies in total in the 2020s, with a very large number of trials listed as active or recruiting in recent years, which supports continued demand for formulation development and process optimization. The manufacturing base is also large enough for small efficiency improvements to matter; according to the U.S. Census Bureau (pharmaceutical and medicine manufacturing, NAICS 3254), shipment values are reported in the hundreds of billions of dollars in the early 2020s, reinforcing why yield, batch consistency, containment, and solvent-handling capability become practical buying criteria for both equipment and outsourced services.
Pharmaceutical Spray Drying Market- Competitive Landscape:
The competitive landscape usually splits into equipment suppliers focused on lab-to-commercial spray drying systems and CDMOs that offer development plus GMP spray drying as a service, often bundled with analytical testing and regulatory documentation. Commonly referenced equipment vendors include GEA Group Aktiengesellschaft (strong in large-scale system engineering and global service coverage), BÜCHI Labortechnik AG (strong in laboratory and pilot tools used in formulation screening and process development), SPX FLOW, Inc. (strong in industrial drying experience and custom builds), Yamato Scientific Co., Ltd. (strong in lab-scale penetration in research environments), and Glatt GmbH (strong in pharmaceutical process equipment engineering and GMP-oriented designs). Commonly referenced service-oriented vendors include Catalent, Inc. (strong in moving programs from development into commercial manufacturing), Lonza Group AG (strong in global GMP manufacturing networks and complex programs), and Hovione, S.A. (strong in particle engineering and enabling formulation work, including inhalation-focused development). In purchasing decisions, the main differentiators tend to be proven scale-up performance, containment level for potent compounds, solvent safety and recovery options, analytical capability for particle and solid-state characterization, and inspection-ready quality systems that reduce technical and regulatory risk.
Recent Developments:
In November 2025, Hovione (a Portugal-based contract development and manufacturing organization, CDMO) completed an initial US$100 million investment round to expand its East Windsor, New Jersey site, taking the footprint to more than 200,000 sq. ft. and more than doubling spray-drying capacity; the first phase adds a 31,000-sq.-ft. building with two size-3 spray dryers (PSD-3) for amorphous solid dispersion (ASD) production, with construction underway and GMP operations targeted for Q2 2026.
In October 2025, Codis (a CDMO formed from the combination of U.S.-based Particle Dynamics and a U.K. spray drying site previously operated by EuroAPI) launched with over 5,000 metric tons per year of spray-drying output capacity, more than 300 employees globally, and 40,000 square meters of manufacturing space across three GMP facilities, positioning the business for commercial-scale ASD, particle engineering, and finished dose manufacturing, while noting seven regulatory approvals achieved.
In September 2024, Serán Bioscience (a CDMO providing development, analytical, and manufacturing services) announced a strategic growth transaction of more than US$200 million led by Bain Capital Life Sciences (with Vivo Capital remaining a key shareholder) to support construction of a new commercial-scale manufacturing facility planned for completion in 2026, expanding integrated capabilities across oral, pulmonary, and nasal delivery with particle-engineering technologies including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, plus finished dose and packaging/serialization; the company cited 200+ team members (including 150+ scientists and engineers) and plans to hire up to 150 additional employees, building toward a nearly 200,000-sq.-ft. campus in Bend, Oregon.
In September 2024, Evonik (a specialty chemicals company and pharmaceutical excipient supplier) opened a new Darmstadt facility for drying aqueous dispersions of EUDRAGIT® polymers, described as a double-digit million-euro investment to expand excipient capacity for oral drug delivery, improve supply security and delivery times, and operate with green electricity and steam from local waste incineration, targeting savings of more than 1,000 CO₂ equivalents per year and alignment with IPEC-GMP guidelines through direct connection to its EUDRAGIT® dispersion production.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
BÜCHI Labortechnik AG
Catalent, Inc.
Dedert Corporation
European SprayDry Technologies LLP
Fette Compacting GmbH
GEA Group Aktiengesellschaft
Glatt GmbH
GMP Pharmaceuticals, LLC
Hovione, S.A.
Labultima
Lonza Group AG
Merck KGaA
New AVM Systech Pvt. Ltd.
SiccaDania A/S
SPX FLOW, Inc.
SÜDMO GmbH
Swenson Technology, Inc.
Tetra Pak International S.A.
Thermo Fisher Scientific Inc.
Yamato Scientific Co., Ltd.
Others
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Spray Dryers (equipment)
Accessories/Consumables
Services (contract spray drying/processing)
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY DRYING CONFIGURATION- MARKET ANALYSIS, 2019 - 2032
Co-current
Counter-current
Mixed-flow
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
APIs (active pharmaceutical ingredients)
Excipients
Finished Dosage Forms (e.g., inhalation, oral solid dosage)
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Pharmaceutical & Biopharmaceutical Companies
Contract Development & Manufacturing Organizations (CDMOs/CMOs)
Research Institutes & Laboratories
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Pharmaceutical Spray Drying Market size was valued at US$ 2,130.30 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.
The pharmaceutical spray drying market focuses on the use of spray drying to turn liquid drug feeds such as solutions, suspensions, or emulsions into dry, free‑flowing powders with controlled particle size, shape, density, and moisture or residual solvent levels. In pharmaceutical research and manufacturing, spray drying is widely treated as more than a simple drying step because it can be used to engineer particles for specific performance targets. It is often chosen when conventional processing cannot achieve the required powder properties, especially for compounds with poor water solubility, unstable actives, or formulations that need precise control over dissolution and dispersibility.
Growth in this market is closely linked to the increasing number of poorly soluble small‑molecule candidates and the need for enabling formulation approaches such as amorphous solid dispersions, as well as the steady expansion of inhalation and nasal drug products where aerodynamic particle size is a critical quality attribute. Spray drying is also applied for taste masking, controlled release, stabilization of sensitive actives, and improving downstream manufacturability for blending, encapsulation, and tableting. For R&D and process development teams, the technology is valued for rapid formulation screening, predictable parameter-based tuning of particle properties, and a clearer path for scale-up when supported by process understanding and Quality by Design frameworks.
Pharmaceutical Spray Drying Market- Market Dynamics
More Poorly Soluble New Drugs and a Busy Approval Cycle Are Driving Spray Drying for Enabling Formulations
A key driver for the pharmaceutical spray drying market is the steady flow of new drug approvals and the growing need to “fix” molecules that do not dissolve well in water, since poor solubility often leads to low and variable absorption and forces formulation teams to use enabling approaches like spray‑dried amorphous solid dispersions or carefully engineered dry powders. The scale of development work is clear in recent approval volumes: According to the U.S. Food and Drug Administration (FDA) CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 NMEs across 2021–2024, which keeps pressure on R&D and manufacturing groups to select scalable processes early. At the pipeline level, the clinical workload remains large and continuous: According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry contains hundreds of thousands of studies overall, with tens of thousands in active or recruiting status in recent years, pointing to a wide base of programs that eventually require formulation optimization and tech transfer. On the production side, demand for reliable, repeatable manufacturing supports investment in particle engineering and drying technologies: According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing), industry shipment values in the early 2020s are reported at hundreds of billions of dollars, meaning small gains in yield, batch consistency, and cycle time can translate into meaningful cost and supply improvements. This combination of a busy approval cycle, a large clinical pipeline, and high-value manufacturing output increases the number of cases where standard crystallization or milling is not enough, making spray drying a practical choice to control particle properties, improve dissolution, and reduce scale-up risk under GMP expectations.
Pharmaceutical Spray Drying Market- Segmentation Analysis:
Outsourced spray drying and processing keeps gaining attention because the development pipeline stays busy and many drug programs need specialized GMP facilities, solvent handling, and fast tech transfer without waiting for new internal capacity. According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the database has grown to well over 400,000 registered studies in the 2020s, with tens of thousands listed as active or recruiting in recent years, which points to a steady stream of formulation and process work moving through R&D. That workload connects directly to commercial readiness, since each successful program eventually needs a scalable and documented manufacturing route. According to U.S. FDA CDER, new molecular entity approvals reached 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, which adds up to 192 NMEs over 2021–2024; this level of approvals keeps pressure on manufacturers and contract partners to lock processes, run validation campaigns, and support launches where spray drying is often considered for particle engineering and consistent powder quality.
Finished dosage manufacturing also supports demand for spray drying because commercial production places high value on batch consistency, predictable powder flow, and controlled particle properties for downstream steps like blending, filling, encapsulation, tableting, or inhalation device performance. According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing, NAICS 3254), U.S. shipment values for this industry are reported in the hundreds of billions of dollars in the early 2020s, showing how even small process gains in yield, cycle time, and deviations can matter financially at scale. Alongside this, according to U.S. FDA CDER annual drug approval reporting, the continuing flow of novel approvals through 2020–2024 supports ongoing lifecycle manufacturing activities such as scale-up, post-approval process changes, and second-source planning, all of which favor robust, repeatable powder-processing methods like spray drying when product performance depends on tight particle control.
Pharmaceutical Spray Drying Market- Geographical Insights
Pharmaceutical spray drying demand tends to concentrate in regions where drug development activity and GMP manufacturing output stay high, because spray drying is usually adopted when a pipeline exists that can move into scale-up and commercial supply. According to U.S. FDA CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 approvals across 2021–2024, which signals a steady flow of products that need manufacturing-ready formulation decisions and controlled powder processing. According to the European Medicines Agency (EMA), the agency continued to publish strong levels of evaluation and authorization activity through the early 2020s, supporting ongoing demand for advanced processing technologies in Europe where compliance and documentation expectations are high. Across Asia, investment tends to follow growth in regulated manufacturing and export-oriented production; according to the World Health Organization (WHO) regulatory system strengthening publications in the early 2020s, more countries have been progressing toward higher maturity regulatory functions, which typically supports broader adoption of GMP-aligned technologies and specialized contract manufacturing capacity.
United States Pharmaceutical Spray Drying Market- Country Insights
The United States looks like the strongest single-country opportunity because it combines approvals, clinical activity, and large-scale manufacturing economics. According to U.S. FDA CDER, the 2021–2024 NME approval run-rate remained high, with annual counts of 50, 37, 55, and 50, which keeps launch timelines and lifecycle manufacturing work active and encourages investment in scalable particle engineering routes such as spray drying. Development depth also remains visible; according to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry includes well over 400,000 studies in total in the 2020s, with a very large number of trials listed as active or recruiting in recent years, which supports continued demand for formulation development and process optimization. The manufacturing base is also large enough for small efficiency improvements to matter; according to the U.S. Census Bureau (pharmaceutical and medicine manufacturing, NAICS 3254), shipment values are reported in the hundreds of billions of dollars in the early 2020s, reinforcing why yield, batch consistency, containment, and solvent-handling capability become practical buying criteria for both equipment and outsourced services.
Pharmaceutical Spray Drying Market- Competitive Landscape:
The competitive landscape usually splits into equipment suppliers focused on lab-to-commercial spray drying systems and CDMOs that offer development plus GMP spray drying as a service, often bundled with analytical testing and regulatory documentation. Commonly referenced equipment vendors include GEA Group Aktiengesellschaft (strong in large-scale system engineering and global service coverage), BÜCHI Labortechnik AG (strong in laboratory and pilot tools used in formulation screening and process development), SPX FLOW, Inc. (strong in industrial drying experience and custom builds), Yamato Scientific Co., Ltd. (strong in lab-scale penetration in research environments), and Glatt GmbH (strong in pharmaceutical process equipment engineering and GMP-oriented designs). Commonly referenced service-oriented vendors include Catalent, Inc. (strong in moving programs from development into commercial manufacturing), Lonza Group AG (strong in global GMP manufacturing networks and complex programs), and Hovione, S.A. (strong in particle engineering and enabling formulation work, including inhalation-focused development). In purchasing decisions, the main differentiators tend to be proven scale-up performance, containment level for potent compounds, solvent safety and recovery options, analytical capability for particle and solid-state characterization, and inspection-ready quality systems that reduce technical and regulatory risk.
Recent Developments:
In November 2025, Hovione (a Portugal-based contract development and manufacturing organization, CDMO) completed an initial US$100 million investment round to expand its East Windsor, New Jersey site, taking the footprint to more than 200,000 sq. ft. and more than doubling spray-drying capacity; the first phase adds a 31,000-sq.-ft. building with two size-3 spray dryers (PSD-3) for amorphous solid dispersion (ASD) production, with construction underway and GMP operations targeted for Q2 2026.
In October 2025, Codis (a CDMO formed from the combination of U.S.-based Particle Dynamics and a U.K. spray drying site previously operated by EuroAPI) launched with over 5,000 metric tons per year of spray-drying output capacity, more than 300 employees globally, and 40,000 square meters of manufacturing space across three GMP facilities, positioning the business for commercial-scale ASD, particle engineering, and finished dose manufacturing, while noting seven regulatory approvals achieved.
In September 2024, Serán Bioscience (a CDMO providing development, analytical, and manufacturing services) announced a strategic growth transaction of more than US$200 million led by Bain Capital Life Sciences (with Vivo Capital remaining a key shareholder) to support construction of a new commercial-scale manufacturing facility planned for completion in 2026, expanding integrated capabilities across oral, pulmonary, and nasal delivery with particle-engineering technologies including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, plus finished dose and packaging/serialization; the company cited 200+ team members (including 150+ scientists and engineers) and plans to hire up to 150 additional employees, building toward a nearly 200,000-sq.-ft. campus in Bend, Oregon.
In September 2024, Evonik (a specialty chemicals company and pharmaceutical excipient supplier) opened a new Darmstadt facility for drying aqueous dispersions of EUDRAGIT® polymers, described as a double-digit million-euro investment to expand excipient capacity for oral drug delivery, improve supply security and delivery times, and operate with green electricity and steam from local waste incineration, targeting savings of more than 1,000 CO₂ equivalents per year and alignment with IPEC-GMP guidelines through direct connection to its EUDRAGIT® dispersion production.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
BÜCHI Labortechnik AG
Catalent, Inc.
Dedert Corporation
European SprayDry Technologies LLP
Fette Compacting GmbH
GEA Group Aktiengesellschaft
Glatt GmbH
GMP Pharmaceuticals, LLC
Hovione, S.A.
Labultima
Lonza Group AG
Merck KGaA
New AVM Systech Pvt. Ltd.
SiccaDania A/S
SPX FLOW, Inc.
SÜDMO GmbH
Swenson Technology, Inc.
Tetra Pak International S.A.
Thermo Fisher Scientific Inc.
Yamato Scientific Co., Ltd.
Others
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Spray Dryers (equipment)
Accessories/Consumables
Services (contract spray drying/processing)
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY DRYING CONFIGURATION- MARKET ANALYSIS, 2019 - 2032
Co-current
Counter-current
Mixed-flow
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
APIs (active pharmaceutical ingredients)
Excipients
Finished Dosage Forms (e.g., inhalation, oral solid dosage)
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Pharmaceutical & Biopharmaceutical Companies
Contract Development & Manufacturing Organizations (CDMOs/CMOs)
Research Institutes & Laboratories
GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
352 Pages
- 1. Pharmaceutical Spray Drying Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
- 2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Pharmaceutical Spray Drying Market Snippet by Product Type
- 2.1.2. Pharmaceutical Spray Drying Market Snippet by Drying Configuration
- 2.1.3. Pharmaceutical Spray Drying Market Snippet by Application
- 2.1.4. Pharmaceutical Spray Drying Market Snippet by End User
- 2.1.5. Pharmaceutical Spray Drying Market Snippet by Country
- 2.1.6. Pharmaceutical Spray Drying Market Snippet by Region
- 2.2. Competitive Insights
- 3. Pharmaceutical Spray Drying Key Market Trends
- 3.1. Pharmaceutical Spray Drying Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Pharmaceutical Spray Drying Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Pharmaceutical Spray Drying Market Opportunities
- 3.4. Pharmaceutical Spray Drying Market Future Trends
- 4. Pharmaceutical Spray Drying Industry Study
- 4.1. PEST Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
- 5. Pharmaceutical Spray Drying Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
- 6. Pharmaceutical Spray Drying Market Landscape
- 6.1. Pharmaceutical Spray Drying Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players’ Analysis
- 6.2.2. Emerging Players’ Analysis
- 7. Pharmaceutical Spray Drying Market – By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Spray Dryers (equipment)
- 7.1.3. Accessories/Consumables
- 7.1.4. Services (contract spray drying/processing)
- 8. Pharmaceutical Spray Drying Market – By Drying Configuration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
- 8.1.2. Co-current
- 8.1.3. Counter-current
- 8.1.4. Mixed-flow
- 9. Pharmaceutical Spray Drying Market – By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. APIs (active pharmaceutical ingredients)
- 9.1.3. Excipients
- 9.1.4. Finished Dosage Forms (e.g., inhalation, oral solid dosage)
- 10. Pharmaceutical Spray Drying Market – By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
- 10.1.2. Pharmaceutical & Biopharmaceutical Companies
- 10.1.3. Contract Development & Manufacturing Organizations (CDMOs/CMOs)
- 10.1.4. Research Institutes & Laboratories
- 11. Pharmaceutical Spray Drying Market– By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Pharmaceutical Spray Drying Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Pharmaceutical Spray Drying Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Pharmaceutical Spray Drying Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Pharmaceutical Spray Drying Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Pharmaceutical Spray Drying Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12. Key Vendor Analysis- Pharmaceutical Spray Drying Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. BÜCHI Labortechnik AG
- 12.2.2. Catalent, Inc.
- 12.2.3. Dedert Corporation
- 12.2.4. European SprayDry Technologies LLP
- 12.2.5. Fette Compacting GmbH
- 12.2.6. GEA Group Aktiengesellschaft
- 12.2.7. Glatt GmbH
- 12.2.8. GMP Pharmaceuticals, LLC
- 12.2.9. Hovione, S.A.
- 12.2.10. Labultima
- 12.2.11. Lonza Group AG
- 12.2.12. Merck KGaA
- 12.2.13. New AVM Systech Pvt. Ltd.
- 12.2.14. SiccaDania A/S
- 12.2.15. SPX FLOW, Inc.
- 12.2.16. SÜDMO GmbH
- 12.2.17. Swenson Technology, Inc.
- 12.2.18. Tetra Pak International S.A.
- 12.2.19. Thermo Fisher Scientific Inc.
- 12.2.20. Yamato Scientific Co., Ltd.
- 12.2.21. Others
- 13. 360 Degree Analyst View
- 14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
